English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 14 Help

Selected(0)Clear Items/Page:    Sort:
Nanoenabled intracellular zinc bursting for efficacious reversal of gefitinib resistance in lung cancer Journal article
Li, Junnan, Assaraf, Yehuda G., Zuo, Weimin, Lin, Ziqi, Leong, Ka Weng, Zhao, Qi, Zhu, Lipeng, Kwok, Hang Fai. Nanoenabled intracellular zinc bursting for efficacious reversal of gefitinib resistance in lung cancer[J]. International Journal of Biological Sciences, 2024, 20(8), 3028-3045.
Authors:  Li, Junnan;  Assaraf, Yehuda G.;  Zuo, Weimin;  Lin, Ziqi;  Leong, Ka Weng; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:8.2/8.3 | Submit date：2024/07/04
Cancer Therapy  Drug Resistance  Lung Cancer  Reactive Oxygen Species (Ros)  Zeolitic Imidazolate Framework-8 (Zif-8)  Zn2++++  
Efficacy and safety of traditional Chinese medicine for cancer-related fatigue: a systematic literature review of randomized controlled trials Review article
2023
Authors:  Yang, Jingya;  Li, Yuxiao;  Chau, Chi Ian;  Shi, Junnan;  Chen, Xianwen; et al.
Favorite | TC[WOS]:4 TC[Scopus]:5  IF:5.3/5.5 | Submit date：2024/01/02
Cancer-related Fatigue  Consort-chm  Rcts  Risk Of Bias  Traditional Chinese Medicine  
Is there a role for traditional and complementary medicines in managing chronic fatigue? a systematic review of randomized controlled trials Journal article
Li, Yuxiao, Yang, Jingya, Chau, Chi Ian, Shi, Junnan, Chen, Xianwen, Hu, Hao, Ung, Carolina Oi Lam. Is there a role for traditional and complementary medicines in managing chronic fatigue? a systematic review of randomized controlled trials[J]. Frontiers in Pharmacology, 2023, 14, 1266803.
Authors:  Li, Yuxiao;  Yang, Jingya;  Chau, Chi Ian;  Shi, Junnan;  Chen, Xianwen; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:4.4/5.0 | Submit date：2024/02/22
Chronic Fatigue Syndrome  Consort-chm  Randomized Clinical Trial  Risk Of Bias  Traditional And Complementary Medicine  
Inhibition of bladder cancer growth with homoharringtonine by inactivating integrin α5/β1-FAK/Src axis: A novel strategy for drug application Journal article
Qiushuang Wu, Pengchen Chen, Junnan Li, Ziqi Lin, Qingwen Zhang, Hang Fai Kwok. Inhibition of bladder cancer growth with homoharringtonine by inactivating integrin α5/β1-FAK/Src axis: A novel strategy for drug application[J]. PHARMACOLOGICAL RESEARCH, 2023, 188, 106654.
Authors:  Qiushuang Wu;  Pengchen Chen;  Junnan Li;  Ziqi Lin;  Qingwen Zhang; et al.
Favorite | TC[WOS]:17 TC[Scopus]:17  IF:9.1/9.0 | Submit date：2023/02/22
Bladder Cancer  Extracellular Matrix  Metastasis  Homoharringtonine  
Synergistic combination of targeted nano-nuclear-reactors and anti-PD-L1 nanobodies evokes persistent T cell immune activation for cancer immunotherapy Journal article
Zhu, Lipeng, Li, Junnan, Guo, Ziang, Kwok, Hang Fai, Zhao, Qi. Synergistic combination of targeted nano-nuclear-reactors and anti-PD-L1 nanobodies evokes persistent T cell immune activation for cancer immunotherapy[J]. Journal of Nanobiotechnology, 2022, 20(1), 521.
Authors:  Zhu, Lipeng;  Li, Junnan;  Guo, Ziang;  Kwok, Hang Fai;  Zhao, Qi
Favorite | TC[WOS]:10 TC[Scopus]:13  IF:10.6/11.4 | Submit date：2023/01/30
Anti-pd-l1 Nanobody  Hypoxia Modulation  Immune-cold Tumors  Immunogenic Cell Death  Nano-nuclear-reactor  t Cell Immune Activation  
A novel combination treatment of antiADAM17 antibody and erlotinib to overcome acquired drug resistance in non-small cell lung cancer through the FOXO3a/FOXM1 axis Journal article
Li, Junnan, Chen, Pengchen, Wu, Qiushuang, Guo, Libin, Leong, Ka Weng, Chan, Kin Iong, Kwok, Hang Fai. A novel combination treatment of antiADAM17 antibody and erlotinib to overcome acquired drug resistance in non-small cell lung cancer through the FOXO3a/FOXM1 axis[J]. Cellular and Molecular Life Sciences, 2022, 79(12), 614.
Authors:  Li, Junnan;  Chen, Pengchen;  Wu, Qiushuang;  Guo, Libin;  Leong, Ka Weng; et al.
Favorite | TC[WOS]:7 TC[Scopus]:6  IF:6.2/7.7 | Submit date：2023/01/30
Antibody Therapy  Cell Death  Drug Target  Precision Oncology  Small Molecule  
RUNDC3A regulates SNAP25-mediated chemotherapy resistance by binding AKT in gastric neuroendocrine carcinoma (GNEC) Journal article
Pengchen Chen, Wei Wang, Sin Wa Wong, Junnan Li, Qiushaung Wu, Shu-Dong Zhang, Yao Lin, Hang Fai Kwok. RUNDC3A regulates SNAP25-mediated chemotherapy resistance by binding AKT in gastric neuroendocrine carcinoma (GNEC)[J]. Cell Death Discovery, 2022, 8(1), 296.
Authors:  Pengchen Chen;  Wei Wang;  Sin Wa Wong;  Junnan Li;  Qiushaung Wu; et al.
Favorite | TC[WOS]:11 TC[Scopus]:11  IF:6.1/6.0 | Submit date：2022/08/01
Signaling Pathways  Drug-resistance  Grade 3  Transcriptome  Neoplasm  Cancer  Tumors  
Nanotechnology-based approaches overcome lung cancer drug resistance through diagnosis and treatment Journal article
Junnan Li, Lipeng Zhu, Hang Fai Kwok. Nanotechnology-based approaches overcome lung cancer drug resistance through diagnosis and treatment[J]. Drug Resistance Updates, 2022, 66, 100904.
Authors:  Junnan Li;  Lipeng Zhu;  Hang Fai Kwok
Favorite | TC[WOS]:40 TC[Scopus]:38  IF:15.8/18.1 | Submit date：2023/02/08
Diagnosis  Drug Resistance  Lung Cancer  Nanoparticles  Treatment  
Plasma-induced defect engineering of porous metal-organic framework nanosheet arrays for efficient water splitting Journal article
Song, Junnan, Zhao, Sheng, Liu, Di, Xiong, Yixing, Hu, Feng, Li, Linlin, Li, Lei, Pan, Hui, Peng, Shengjie. Plasma-induced defect engineering of porous metal-organic framework nanosheet arrays for efficient water splitting[J]. Chemical Communications, 2022, 58(69), 9662-9665.
Authors:  Song, Junnan;  Zhao, Sheng;  Liu, Di;  Xiong, Yixing;  Hu, Feng; et al.
Favorite | TC[WOS]:22 TC[Scopus]:22  IF:4.3/4.4 | Submit date：2023/01/30
Integrating real-world evidence in the regulatory decision-making process: a systematic documentary analysis of experiences in the US, EU and China using a logic model Journal article
Li, Meng, Chen, Shengqi, Lai, Yunfeng, Liang, Zuanji, Wang, Jiaqi, Shi, Junnan, Lin, Haojie, Yao, Dongning, Hu, Hao, Ung, Carolina Oi Lam. Integrating real-world evidence in the regulatory decision-making process: a systematic documentary analysis of experiences in the US, EU and China using a logic model[J]. Frontiers in Medicine, 2021, 8, 669509.
Authors:  Li, Meng;  Chen, Shengqi;  Lai, Yunfeng;  Liang, Zuanji;  Wang, Jiaqi; et al.
Favorite | TC[WOS]:23 TC[Scopus]:30  IF:3.1/3.4 | Submit date：2022/07/27
Regulatory Science  Real-world Evidence  Decision-making  Logic Model  Regulation